{"id":"https://openalex.org/W2045367162","doi":"https://doi.org/10.1097/qai.0b013e3182084b5a","title":"Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1\u2013Infected Adults on Antiretroviral Therapy in C\u00f4te d'Ivoire","display_name":"Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1\u2013Infected Adults on Antiretroviral Therapy in C\u00f4te d'Ivoire","publication_year":2010,"publication_date":"2010-12-30","ids":{"openalex":"https://openalex.org/W2045367162","doi":"https://doi.org/10.1097/qai.0b013e3182084b5a","mag":"2045367162","pmid":"https://pubmed.ncbi.nlm.nih.gov/21191309","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3050083"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0b013e3182084b5a","doi":"https://doi.org/10.1097/qai.0b013e3182084b5a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e3182084b5a","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3050083","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110527695","display_name":"Eug\u00e8ne Messou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI","FR"],"is_corresponding":true,"raw_author_name":"Eug\u00e8ne Messou","raw_affiliation_strings":["Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]},{"raw_affiliation_string":"INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066083849","display_name":"Marie\u2010Laure Chaix","orcid":"https://orcid.org/0000-0002-7798-4621","observed_orcids":["https://orcid.org/0000-0002-7798-4621"]},"institutions":[{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Laure Chaix","raw_affiliation_strings":["Universit\u00e9 Paris Descartes, EA 3620, Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris Descartes, EA 3620, Paris","institution_ids":["https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107868014","display_name":"Delphine Gabillard","orcid":"https://orcid.org/0000-0002-9122-2674","observed_orcids":["https://orcid.org/0000-0002-9122-2674"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI","FR"],"is_corresponding":true,"raw_author_name":"Delphine Gabillard","raw_affiliation_strings":["INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]},{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063663542","display_name":"Albert Kla Minga","orcid":"https://orcid.org/0000-0003-2357-6902","observed_orcids":["https://orcid.org/0000-0003-2357-6902"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI","FR"],"is_corresponding":true,"raw_author_name":"Albert Minga","raw_affiliation_strings":["INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]},{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019522183","display_name":"Elena Losina","orcid":"https://orcid.org/0000-0002-3424-0892","observed_orcids":["https://orcid.org/0000-0002-3424-0892","https://orcid.org/0000-0001-8229-6674"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Losina","raw_affiliation_strings":["Massachusetts General Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029835674","display_name":"Vincent Yapo","orcid":"https://orcid.org/0009-0002-8829-6880","observed_orcids":["https://orcid.org/0009-0002-8829-6880"]},"institutions":[{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]},{"id":"https://openalex.org/I4210154592","display_name":"University Hospital Medical Center at Treichville","ror":"https://ror.org/056221z03","country_code":"CI","type":"healthcare","lineage":["https://openalex.org/I4210154592"]}],"countries":["CI"],"is_corresponding":true,"raw_author_name":"Vincent Yapo","raw_affiliation_strings":["CeDReS, CHU de Treichville, Abidjan, C\u00f4te d'Ivoire","Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CeDReS, CHU de Treichville, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210154592"]},{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057579434","display_name":"Martial Kouakou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI"],"is_corresponding":true,"raw_author_name":"Martial Kouakou","raw_affiliation_strings":["Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049211238","display_name":"Christine Danel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI","FR"],"is_corresponding":true,"raw_author_name":"Christine Danel","raw_affiliation_strings":["INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]},{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015116905","display_name":"Caroline E. Sloan","orcid":"https://orcid.org/0000-0003-1611-3846","observed_orcids":["https://orcid.org/0000-0003-1611-3846"]},"institutions":[{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI"],"is_corresponding":true,"raw_author_name":"Caroline Sloan","raw_affiliation_strings":["Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107838912","display_name":"Christine Rouzioux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Rouzioux","raw_affiliation_strings":["Universit\u00e9 Paris Descartes, EA 3620, Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris Descartes, EA 3620, Paris","institution_ids":["https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074313423","display_name":"Kenneth A. Freedberg","orcid":"https://orcid.org/0000-0001-6471-7930","observed_orcids":["https://orcid.org/0000-0001-6471-7930","https://orcid.org/0000-0003-3143-7822"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth A Freedberg","raw_affiliation_strings":["Massachusetts General Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024120430","display_name":"Xavier Anglaret","orcid":"https://orcid.org/0000-0003-3319-8423","observed_orcids":["https://orcid.org/0000-0003-3319-8423"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210143164","display_name":"Programme PAC-CI","ror":"https://ror.org/03jtajd40","country_code":"CI","type":"other","lineage":["https://openalex.org/I4210116296","https://openalex.org/I4210143164"]}],"countries":["CI","FR"],"is_corresponding":true,"raw_author_name":"Xavier Anglaret","raw_affiliation_strings":["INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U897, Universit\u00e9 Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]},{"raw_affiliation_string":"Programme PAC-CI/ANRS, Abidjan, C\u00f4te d'Ivoire","institution_ids":["https://openalex.org/I4210143164"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5015116905","https://openalex.org/A5024120430","https://openalex.org/A5029835674","https://openalex.org/A5049211238","https://openalex.org/A5057579434","https://openalex.org/A5063663542","https://openalex.org/A5107868014","https://openalex.org/A5110527695"],"corresponding_institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488","https://openalex.org/I4210143164","https://openalex.org/I4210154592"],"apc_list":null,"apc_paid":null,"fwci":4.0317,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.93678821,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"56","issue":"4","first_page":"356","last_page":"364"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9120000004768372},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.7319999933242798},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7609999775886536},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.8149999976158142},{"id":"https://openalex.org/keywords/resistance-mutations","display_name":"resistance mutations","score":0.7519999742507935},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.6959999799728394},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9539999961853027},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.8100000023841858},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cote-d-ivoire","display_name":"C\u00f4te d'Ivoire","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.8706260919570923},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.8311805129051208},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.7945621609687805},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.7162303924560547},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6919608116149902},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.6625210046768188},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5739258527755737},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.567805290222168},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5588203072547913},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.5442242622375488},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4923306703567505},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.49210184812545776},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.47897934913635254},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4613637328147888},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.4564010202884674},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.3852721154689789},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2864508628845215},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.24961581826210022},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.20138758420944214},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1376885175704956},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.10395124554634094},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.07840624451637268},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06436127424240112},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003625","descriptor_name":"Data Collection","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007560","descriptor_name":"Cote d'Ivoire","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/qai.0b013e3182084b5a","doi":"https://doi.org/10.1097/qai.0b013e3182084b5a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e3182084b5a","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:21191309","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21191309","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2320934","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3050083","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3050083","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3050083","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Acquir Immune Defic Syndr","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2320934","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3050083","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1715512604","display_name":"Optimal Strategies for Management of HIV Disease","funder_award_id":"K24AI062476","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000920291","display_name":"Optimizing HIV Care in Less Developed Countries","funder_award_id":"R01AI058736","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W89827783","https://openalex.org/W1951712651","https://openalex.org/W1964020548","https://openalex.org/W1971334912","https://openalex.org/W1973489201","https://openalex.org/W1975850502","https://openalex.org/W1980520085","https://openalex.org/W1986667969","https://openalex.org/W1998210875","https://openalex.org/W2004152021","https://openalex.org/W2006910736","https://openalex.org/W2011608109","https://openalex.org/W2020086850","https://openalex.org/W2032240325","https://openalex.org/W2032952072","https://openalex.org/W2042085468","https://openalex.org/W2047274488","https://openalex.org/W2048383566","https://openalex.org/W2054322922","https://openalex.org/W2057112394","https://openalex.org/W2058404981","https://openalex.org/W2063611994","https://openalex.org/W2064000153","https://openalex.org/W2064871165","https://openalex.org/W2065654485","https://openalex.org/W2077020785","https://openalex.org/W2078908246","https://openalex.org/W2079201451","https://openalex.org/W2085243794","https://openalex.org/W2101188907","https://openalex.org/W2120293408","https://openalex.org/W2130715578","https://openalex.org/W2138574631","https://openalex.org/W2140243859","https://openalex.org/W2142232262","https://openalex.org/W2150340704","https://openalex.org/W2170507689"],"related_works":["https://openalex.org/W4353015215","https://openalex.org/W2033994684","https://openalex.org/W1973489201","https://openalex.org/W1964142134","https://openalex.org/W4393005426","https://openalex.org/W2605020878","https://openalex.org/W2793424642","https://openalex.org/W4221054243","https://openalex.org/W2048383566","https://openalex.org/W4402275118"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adherence":[1],"is":[2,16],"a":[3,51],"strong":[4],"determinant":[5],"of":[6,55,99,102,112,147,166,221],"viral":[7,69],"suppression":[8],"with":[9,26,124,158,164,177,195,217,223],"antiretroviral":[10,103],"therapy":[11],"(ART)":[12],"but":[13,207],"measuring":[14],"it":[15],"challenging.":[17],"Medication":[18],"delivery":[19],"can":[20],"be":[21,234],"measured":[22],"accurately":[23],"in":[24,45,60,139],"settings":[25],"computerized":[27,64],"prescription":[28],"databases.":[29],"We":[30,49],"studied":[31],"the":[32,97,109,175],"association":[33],"between":[34],"medication":[35],"possession":[36],"ratio":[37],"(MPR),":[38],"virologic":[39,218],"suppression,":[40],"and":[41,77,84,132,135,144,155,171,190],"resistance":[42,160,230],"to":[43,203,209,238,247],"ART":[44,59,82,116,123],"C\u00f4te":[46],"d'Ivoire.":[47],"METHODS:":[48],"conducted":[50],"prospective":[52],"cohort":[53],"study":[54],"HIV-1-infected":[56],"adults":[57],"initiating":[58],"3":[61],"clinics":[62],"using":[63],"monitoring":[65],"systems.":[66],"Patients":[67],"had":[68,149,228],"load":[70],"(VL)":[71],"tests":[72,86],"at":[73,173,198,226,236],"month":[74,78],"6":[75],"(M6)":[76,143,154],"12":[79],"(M12)":[80,146,157],"after":[81],"initiation":[83],"genotype":[85],"if":[87],"VL":[88,179,225],"was":[89,94,181,214],"detectable":[90,150,178,224],"(\u2265300":[91],"copies/mL).":[92],"MPR":[93,165,213,232],"defined":[95],"as":[96],"number":[98,111],"daily":[100],"doses":[101],"drug":[104],"actually":[105],"provided":[106],"divided":[107],"by":[108],"total":[110],"follow-up":[113],"days":[114],"since":[115],"initiation.":[117],"RESULTS:":[118],"Overall,":[119],"1573":[120],"patients":[121,137,148,163,194,240],"started":[122],"stavudine/zidovudine":[125],"plus":[126,128],"lamivudine":[127],"nevirapine/efavirenz.":[129],"At":[130],"M6":[131,237],"M12,":[133,174,199],"996":[134],"942":[136],"were":[138,201],"active":[140],"follow-up;":[141],"20%":[142],"25%":[145],"VL,":[151],"including":[152],"7%":[153],"11%":[156],"\u22651":[159,196],"mutation.":[161],"Among":[162,193],"\u226595%,":[167],"80%-94%,":[168],"65%-79%,":[169],"50%-64%,":[170],"<50%":[172],"proportion":[176],"[resistance]":[180],"9%":[182],"[4%],":[183],"17%":[184],"[7%],":[185],"45%":[186],"[24%],":[187],"67%":[188],"[31%],":[189],"85%":[191],"[37%].":[192],"mutation":[197],"86%":[200],"resistant":[202],"lamivudine/emtricitabine":[204],"and/or":[205],"nevirapine/efavirenz":[206],"not":[208],"other":[210],"drugs.":[211],"CONCLUSIONS:":[212],"strongly":[215],"associated":[216],"outcomes.":[219],"Half":[220],"those":[222],"M12":[227],"no":[229],"mutations.":[231],"should":[233],"used":[235],"identify":[239],"who":[241],"might":[242],"benefit":[243],"from":[244],"early":[245],"interventions":[246],"reinforce":[248],"adherence.":[249]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}